GL1X · GenesisL1 explorer

MolNFT v1 · #19026 · protein

Crystal structure of the complex formed between RUSSELL'S viper phospholipase A2 and an antiinflammatory agent oxyphenbutazone at 1.6A resolution

1Q7A · Phospholipase A2 vrv-pl-viiia: “Crystal structure of the complex formed between RUSSELL'S viper phospholipase A2 and an antiinflammatory…”. X-ray diffraction, 2 ligands (OPB, SO4), 1 pocket (best druggability 0.52). MolNFT v1 #19026…

PDB
1Q7A
Type
protein
Length
121 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phospholipase A2 vrv-pl-viiia
EC
3.1.1.4
UniProt
P59071
Ligands
OPB, SO4
Pockets
1 · best druggability 0.52

Structure

x-ray diffraction · 1 distinct chain · 48% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhospholipase A2 vrv-pl-viiia (EC 3.1.1.4)protein12148% helix, 9% strandP59071

Ligands and binding sites

  • OPB · 4-butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione · ligand · chains A
  • SO4 · Sulfate ion · ion · 2 copies · chains A
  • MOH · Methanol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11610.520.7919OPB, MOH

Modifications

Observed in the structure: 7 disulfide (disulfide).

Compared structures

  • 1Q7A · Crystal structure of the complex formed between russell's viper phospholipase A2 and an… · the same entry in another collection · chain A against A, TM-score 1.00
  • P59071 · AlphaFold monomer V2.0 prediction for basic phospholipase A2 vrv-pl- viiia (P59071) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.